Tri Locum Partners’s AbbVie ABBV Stock Holding History

Tri Locum Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-89,621	Closed	-$20.8M	–	16
2025 Q3	$20.8M	Buy	89,621 +33,960	+61%	+$6.92M	4.77%	10
2025 Q2	$10.3M	Buy	+55,661	New	+$10.3M	3.14%	12
2024 Q1	–	Sell	-167,807	Closed	-$26M	–	28
2023 Q4	$26M	Buy	167,807 +23,246	+16%	+$3.39M	11.89%	1
2023 Q3	$21.5M	Buy	+144,561	New	+$21.2M	6.89%	4
2023 Q2	–	Sell	-49,213	Closed	-$7.84M	–	60
2023 Q1	$7.84M	Buy	+49,213	New	+$7.52M	2.39%	17
2022 Q1	–	Sell	-179,950	Closed	-$24.4M	–	38
2021 Q4	$24.4M	Buy	+179,950	New	+$21.3M	9.59%	1
2021 Q1	–	Sell	-193,223	Closed	-$20.7M	–	35
2020 Q4	$20.7M	Buy	+193,223	New	+$18.6M	7.52%	4

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Tri Locum Partners's ABBV Position: Q4 2025 in Review

Tri Locum Partners sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 89,621 shares — an estimated $20.8M sold.

Tri Locum Partners first reported a position in ABBV in Q4 2020 and held it in 7 quarters. The position peaked at $26M in Q4 2023. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Tri Locum Partners reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Tri Locum Partners sold 89,621 AbbVie shares in Q4 2025, an estimated $20.8M.
Tri Locum Partners first reported a position in AbbVie in Q4 2020 and held it in 7 quarters.
Tri Locum Partners's AbbVie position peaked at $26M in Q4 2023.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Tri Locum Partners's 13F filing for Q4 2025, filed 17 Feb 2026.